Published in Hepatitis Weekly, October 28th, 2002
She will assume responsibility for all financial, strategic planning, investor relations, information technology, and facilities functions at InterMune reporting to Scott Harkonen, president and CEO.
Surrey-Barbari joins InterMune from Gilead Sciences, Inc., where she most recently served as its vice president and CFO.
"Sharon brings nearly 30 years of biopharmaceutical financial operations and commercial experience to InterMune's senior management team," said Harkonen. "The breadth of her background and extensive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.